Wuest Melinda, Eichhorn Birgit, Grimm Marc O, Wirth Manfred P, Ravens Ursula, Kaumann Alberto J
Department of Pharmacology and Toxicology, Dresden University of Technology, Fetscher-strasse 74, 01307 Dresden, Germany.
J Pharmacol Exp Ther. 2009 Jan;328(1):213-22. doi: 10.1124/jpet.108.142562. Epub 2008 Sep 26.
(-)-Isoproterenol [4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-1,2-benzene diol hydrochloride] relaxes murine detrusor through beta-adrenoceptors (ARs); however, the beta-AR subtypes involved are unknown. beta(2)-ARs have been associated with caveolae, plasma-lemmal scaffolding domains that are absent in caveolin-1 (cav-1) knockout (KO) mice. Here, we studied detrusor responses in the absence and presence of beta-AR subtype-selective antagonists in wild-type (WT) and cav-1 KO mice. To inquire whether the murine detrusor model is relevant to man, beta-AR subtypes that mediate (-)-isoproterenol-evoked human detrusor relaxation were investigated. In WT mice, (-)-isoproterenol concentration-dependently relaxed the KCl (40 mM)-precontracted detrusor (-logEC(50)M = 8.04, E(max) = 62%). The effects of (-)-isoproterenol were surmountably antagonized by the beta(2)-AR-selective antagonist ICI 118,551 [(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol] (pK(B) = 9.28) but not affected by the beta(1)-AR-selective antagonist CGP 20712 [1-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol] and beta(3)-AR-selective L-748,337 [(S)-M-[4-[2-[3-[3-[acetamidomethyl)phenoxy)-2-hydroxypropyl]-amino]-ethyl]-phenylbenzsulfonamide)], suggesting involvement of beta(2)-AR only. The cav-1 KO detrusor displayed significant contractile dysfunction. (-)-Isoproterenol was less potent and efficient in relaxing detrusor from cav-1 KO (-logEC(50)M, 7.76; E(max) = 44%), but ICI 118,551 caused similar antagonism (pK(B) = 9.15), suggesting that beta(2)-AR function persisted in cav-1 KO. The beta(3)-AR-selective antagonist L-748,337 in the presence of ICI 118,551 and CGP 20712 caused additional blockade of (-)-isoproterenol effects in cav-1 KO, consistent with a beta(3)-AR involvement during relaxation and suppression of this effect in WT. (-)-Isoproterenol relaxed human detrusor muscle precontracted with carbachol (-logEC(50)M = 6.39, E(max) = 52%). However, the effects of (-)-isoproterenol in human detrusor were not blocked by CGP 20712 or ICI 118,551 but antagonized by L-748,337 (pK(B) = 7.65). We conclude that murine detrusor relaxation occurs via beta(2)-AR, and loss of caveolae does not perturb beta(2)-AR function but unmasks an additional activation of beta(3)-AR. In contrast, detrusor relaxation in man is mediated exclusively via beta(3)-AR.
(-)-异丙肾上腺素[4-[1-羟基-2-[(1-甲基乙基)氨基]乙基]-1,2-苯二酚盐酸盐]通过β-肾上腺素能受体(ARs)使小鼠逼尿肌松弛;然而,所涉及的β-AR亚型尚不清楚。β(2)-ARs与小窝相关,小窝是质膜支架结构域,在小窝蛋白-1(cav-1)基因敲除(KO)小鼠中不存在。在此,我们研究了野生型(WT)和cav-1 KO小鼠在有无β-AR亚型选择性拮抗剂情况下逼尿肌的反应。为探究小鼠逼尿肌模型是否与人类相关,我们研究了介导(-)-异丙肾上腺素诱发人类逼尿肌松弛的β-AR亚型。在WT小鼠中,(-)-异丙肾上腺素浓度依赖性地使氯化钾(40 mM)预收缩的逼尿肌松弛(-logEC(50)M = 8.04,E(max)=62%)。(-)-异丙肾上腺素的作用可被β(2)-AR选择性拮抗剂ICI 118,551 [(+/-)-1-[2,3-(二氢-7-甲基-1H-茚-4-基)氧基]-3-[(1-甲基乙基)氨基]-2-丁醇](pK(B)=9.28)竞争性拮抗,但不受β(1)-AR选择性拮抗剂CGP 20712 [1-[2-((3-氨基甲酰基-4-羟基)苯氧基)乙基氨基]-3-[4-(1-甲基-4-三氟甲基-2-咪唑基)苯氧基]-2-丙醇]和β(3)-AR选择性L-748,337 [(S)-M-[4-[2-[3-[3-(乙酰氨基甲基)苯氧基)-2-羟丙基]-氨基]-乙基]-苯磺酰胺]影响,提示仅涉及β(2)-AR。cav-1 KO逼尿肌表现出明显的收缩功能障碍。(-)-异丙肾上腺素在松弛cav-1 KO小鼠逼尿肌方面效力和效率较低(-logEC(50)M,7.76;E(max)=44%),但ICI 118,551产生类似的拮抗作用(pK(B)=9.15),提示β(2)-AR功能在cav-1 KO小鼠中持续存在。在ICI 118,551和CGP 20712存在的情况下,β(3)-AR选择性拮抗剂L-748,337对(-)-异丙肾上腺素在cav-1 KO小鼠中的作用产生额外阻断,这与β(3)-AR在WT小鼠松弛过程中的参与以及对该作用抑制一致。(-)-异丙肾上腺素使卡巴胆碱预收缩的人类逼尿肌松弛(-logEC(50)M = 6.39,E(max)=52%)。然而,(-)-异丙肾上腺素在人类逼尿肌中的作用未被CGP 20712或ICI 118,551阻断,但被L-748,337拮抗(pK(B)=7.65)。我们得出结论,小鼠逼尿肌松弛通过β(2)-AR发生,小窝的缺失不会干扰β(2)-AR功能,但会揭示β(3)-AR的额外激活。相比之下,人类逼尿肌松弛仅通过β(3)-AR介导。